Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Integra Therapeutics Logo
Integra Therapeutics Growth Score
61
CB Rank
111152
Heat Score
23
Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
Founded
obfuscation
PrivateSeed Barcelona, Catalonia, Spain11-50 integra-tx.com/
Biotechnology
Genetics
Health Care
Overview

Integra Therapeutics
Total Funding
obfuscation
Growth Score
61
Heat Score
23

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score61
-8 pts
in past quarter
Heat Score 23
-8 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Integra Therapeutics

CB Rank
111152
Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
Founded
obfuscation
PrivateSeed Barcelona, Catalonia, Spain11-50 integra-tx.com/
Biotechnology
Genetics
Health Care

Funding Rounds

Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Legal Name Integra Therapeutics
Operating Status Active
Company Type For Profit
Founders  Avencia Sanchez-Mejias, Marc Güell
About the Company
Integra Therapeutics is a developer of next-generation of gene editing tools to cure diseases.
Contact Email info@integra-tx.com
Predictions & Insights

Growth Insight

See this Growth Insight
Integra Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

FiCAT
A gene writing technology that combines CRISPR-Cas9 for precision and an engineered PiggyBac transposase for efficient DNA insertion, applicable in both in vivo and ex vivo therapies.
Gene Writing Platform
Designed for the development of gene therapies, this platform enables precise DNA insertion to treat genetic and oncological diseases.

Research & Development

Integra Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Integra Therapeutics Logo
Seed Round - Integra Therapeutics
3
obfuscation
— Seed
obfuscation
Seed Round - Integra Therapeutics Logo
Seed Round - Integra Therapeutics
3
obfuscation
— Seed
obfuscation
Seed Round - Integra Therapeutics Logo
Seed Round - Integra Therapeutics
3
obfuscation
— Seed
obfuscation
Seed Round - Integra Therapeutics Logo
Seed Round - Integra Therapeutics
3
obfuscation
— Seed
obfuscation
Seed Round - Integra Therapeutics Logo
Seed Round - Integra Therapeutics
3
obfuscation
— Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Integra Therapeutics Logo
Seed Round - Integra Therapeutics
3
obfuscation
— Seed
obfuscation
Seed Round - Integra Therapeutics Logo
Seed Round - Integra Therapeutics
3
obfuscation
— Seed
obfuscation
Seed Round - Integra Therapeutics Logo
Seed Round - Integra Therapeutics
3
obfuscation
— Seed
obfuscation
Seed Round - Integra Therapeutics Logo
Seed Round - Integra Therapeutics
3
obfuscation
— Seed
obfuscation
Seed Round - Integra Therapeutics Logo
Seed Round - Integra Therapeutics
3
obfuscation
— Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
AdBio partners Logo
AdBio partners
—
Seed Round - Integra Therapeutics Logo
Seed Round - Integra Therapeutics
—
AdBio partners Logo
AdBio partners
—
Seed Round - Integra Therapeutics Logo
Seed Round - Integra Therapeutics
—
AdBio partners Logo
AdBio partners
—
Seed Round - Integra Therapeutics Logo
Seed Round - Integra Therapeutics
—
AdBio partners Logo
AdBio partners
—
Seed Round - Integra Therapeutics Logo
Seed Round - Integra Therapeutics
—
AdBio partners Logo
AdBio partners
—
Seed Round - Integra Therapeutics Logo
Seed Round - Integra Therapeutics
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2 Board Members and Advisors 2 Contacts 4

Employee Profiles

Board Members and Advisors

News

News and Press

News•May 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 4, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 6, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 5, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

2,147
221.41%
 in past month

IT Spend

$223.9KThis year, Integra Therapeutics is projected to spend $223.9K on IT, according to Aberdeen.

Active Website Tech Count

6Integra Therapeutics is actively using 6 technologies for its website, according to BuiltWith. These include Common Crawl, Google Font API, and  CommonCrawl Top 5m.

Total IP

3The intellectual property of Integra Therapeutics includes 3 registered patents primarily in the 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Integra Therapeutics's headquarters? Integra Therapeutics is located in Barcelona, Catalonia, Spain.Who invested in Integra Therapeutics? Integra Therapeutics has 7 investors including AdBio partners and  Columbus Venture Partners.When was the last funding round for Integra Therapeutics? Integra Therapeutics closed its last funding round on
obfuscation
from a Seed round.Who are Integra Therapeutics's competitors? Alternatives and possible competitors to Integra Therapeutics may include Scribe Therapeutics, Tessera Therapeutics, and  Prime Medicine.How much funding has Integra Therapeutics raised to date? Integra Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(2e7868f 1)
|